This page in English

Niklas Zethraeus

Forskare

Postadress : Institutionen för lärande, informatik, management och etik (LIME), C7, MMC/Health Economics and Economic Evaluation, Nobels väg 15A, 171 77 Stockholm

Publikationer

Combined Oral Contraceptives and Sexual Function in Women-a Double-Blind, Randomized, Placebo-Controlled Trial
Zethraeus N, Dreber A, Ranehill E, Blomberg L, Labrie F, Von Schoultz B, et al
The Journal of clinical endocrinology and metabolism 2016;101(11):4046-4053

Cost-effectiveness of case-based training for primary care physicians in evidence-based medicine of patients with coronary heart disease
Groot-jensen S, Kiessling A, Zethraeus N, Björnstedt-bennermo M, Henriksson P
European journal of preventive cardiology 2016;23(4):420-7

Assessment of the Swedish EQ-5D experience-based value sets in a total hip replacement population
Nemes S, Burström K, Zethraeus N, Eneqvist T, Garellick G, Rolfson O
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2015;24(12):2963-70

Barriers to and facilitators of compliance with clinic-based cervical cancer screening: population-based cohort study of women aged 23-60 years
Östensson E, Alder S, Elfström Km, Sundström K, Zethraeus N, Arbyn M, et al
PloS one 2015;10(5):e0128270-

Cost and effects of a universal parenting programme delivered to parents of preschoolers
Sampaio F, Sarkadi A, Salari R, Zethraeus N, Feldman I
European journal of public health 2015;25(6):1035-42

Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination
Östensson E, Fröberg M, Leval A, Hellström Ac, Bäcklund M, Zethraeus N, et al
PloS one 2015;10(9):e0139062-

Integrative medicine for back and neck pain: Exploring cost-effectiveness alongside a randomized clinical pilot trial
Sundberg T, Hagberg L, Zethraeus N, Wandell P, Falkenberg T
EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE 2014;6(1):29-38

Swedish experience-based value sets for EQ-5D health states
Burström K, Sun S, Gerdtham Ug, Henriksson M, Johannesson M, Levin LÅ, et al
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2014;23(2):431-42

Projected cost-effectiveness of repeat high-risk human papillomavirus testing using self-collected vaginal samples in the Swedish cervical cancer screening program
Östensson E, Hellström Ac, Hellman K, Gustavsson I, Gyllensten U, Wilander E, et al
Acta obstetricia et gynecologica Scandinavica 2013;92(7):830-40

A randomized trial of the effect of testosterone and estrogen on verbal fluency, verbal memory, and spatial ability in healthy postmenopausal women
Kocoska-maras L, Zethraeus N, Raddestad Af, Ellingsen T, Von Schoultz B, Johannesson M, et al
FERTILITY AND STERILITY 2011;95(1):152-7

Economic analysis of human papillomavirus triage, repeat cytology, and immediate colposcopy in management of women with minor cytological abnormalities in Sweden
Ostensson E, Froberg M, Hjerpe A, Zethraeus N, Andersson S
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA 2010;89(10):1316-25

Health-care cost reduction resulting from primary-care allergy testing in children in Italy
Zethraeus N, Petersson Cj, Dozzi M, Borres Mp, Vignati G, Fiocchi A
ITALIAN JOURNAL OF PEDIATRICS 2010;:61-

A randomized trial of the effect of estrogen and testosterone on economic behavior
Zethraeus N, Kocoska-maras L, Ellingsen T, Von Schoultz B, Hirschberg Al, Johannesson M
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2009;106(16):6535-8

Cost-effectiveness of hormone replacement therapy for menopausal symptoms in the UK
Lekander I, Borgström F, Ström O, Zethraeus N, Kanis Ja
Menopause international 2009;15(1):19-25

Cost-Effectiveness of Hormone Therapy in the United States
Lekander I, Borgstrom F, Strom O, Zethraeus N, Kanis Ja
JOURNAL OF WOMENS HEALTH 2009;18(10):1669-77

Cost effectiveness of hormone therapy in women at high risks of fracture in Sweden, the US and the UK - Results based on the Women's Health Initiative randomised controlled trial
Lekander I, Borgstrom F, Strom O, Zethraeus N, Kanis Ja
BONE 2008;42(2):294-306

Long-term cost and effect on quality of life of osteoporosis-related fractures in Sweden
Strom O, Borgstrom F, Zethraeus N, Johnell O, Lidgren L, Ponzer S, et al
ACTA ORTHOPAEDICA 2008;79(2):269-80

The cost-effectiveness of the treatment of high risk women with osteoporosis, hypertension and hyperlipidaemia in Sweden
Zethraeus N, Strom O, Borgstrom F, Kanis Ja, Jonsson B
OSTEOPOROSIS INTERNATIONAL 2008;19(6):819-27

Cost-effectiveness of the treatment and prevention of osteoporosis - a review of the literature and a reference model
Zethraeus N, Borgstrom F, Strom O, Kanis Ja, Jonsson B
OSTEOPOROSIS INTERNATIONAL 2007;18(1):9-23

Long term quality of life related to osteoporotic fractures. 13-18 months after fracture
Strom O, Borgstrom F, Zethraeus N, Johnell O, Jonsson B
OSTEOPOROSIS INTERNATIONAL 2007;:S6-S6

Cost consequences of preoperative duplex examination before varicose vein surgery: a randomized clinical trial
Blomgren L, Zethraeus N, Johansson G, Jonsson B, Bergqvist D
PHLEBOLOGY 2006;21(2):90-95

Cost-effectiveness analysis of using allergy tests in primary care in Italian children
Ytterstrom-ahlstedt U, Zethraeus N, Petersson Cj, Ahlstedt S
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 2006;117(2):S135-S135

Costs and quality of life associated with osteoporosis-related fractures in Sweden
Borgstrom F, Zethraeus N, Johnell O, Lidgren L, Ponzer S, Svensson O, et al
OSTEOPOROSIS INTERNATIONAL 2006;17(5):637-50

Long term quality of life related to osteoporotic fractures; 13-18 months after fracture
Strom O, Borgstrom F, Zethraeus N, Jonsson B
VALUE IN HEALTH 2006;9(6):A383-A383

What is the risk of institutionalization after hip fracture?
Zethraeus N, Strom O, Borgstrom F
OSTEOPOROSIS INTERNATIONAL 2006;:S57-S58

What is the risk of institutionalization after hip fracture?
Zethraeus N, Strom Oe, Borgstrom F
OSTEOPOROSIS INTERNATIONAL 2006;:S184-S184

Assessment of fracture risk
Kanis Ja, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B, et al
OSTEOPOROSIS INTERNATIONAL 2005;16(6):581-9

Cost of lipid lowering in patients with coronary artery disease by Case Method Learning
Kiessling A, Zethraeus N, Henriksson P
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 2005;21(2):180-6

Intervention thresholds for osteoporosis in the UK
Kanis Ja, Borgsrom F, Zethraeus N, Johnell O, Oden A, Jonsson B
BONE 2005;36(1):22-32

Reassessment of the cost-effectiveness of hormone replacement therapy in Sweden: Results based on the Women's Health Initiative randomized controlled trial
Zethraeus N, Borgstrom F, Jonsson B, Kanis J
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 2005;21(4):433-41

Case method learning is a cost effective implementation method of evidence based secondary prevention in primary care
Kiessling A, Zethraeus N, Henriksson P
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 2004;43(5):408A-408A

Cost effectiveness of alendronate for the treatment of male osteoporosis in Sweden
Borgstrom F, Johnell O, Johnsson B, Zethraeus N, Sen Ss
BONE 2004;34(6):1064-71

Costs and quality of life related to vertebral fractures: Preliminary results based on an ongoing Swedish prospective study
Zethraeus N, Borgstrom F, Jonsson B
OSTEOPOROSIS INTERNATIONAL 2004;:S52-S53

The cost effectiveness of hormone replacement therapy (HRT) for women with menopasual symptoms in Sweden
Borgstrom F, Zethraeus N, Johnell O, Kanis J, Jonsson B
VALUE IN HEALTH 2004;7(6):691-692

The risk and burden of vertebral fractures in Sweden
Kanis Ja, Johnell O, Oden A, Borgstrom F, Zethraeus N, De Laet C, et al
OSTEOPOROSIS INTERNATIONAL 2004;15(1):20-6

Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies
Zethraeus N, Johannesson M, Jonsson B, Lothgren M, Tambour M
PHARMACOECONOMICS 2003;21(1):39-48

[Cost-effectiveness of alendronate treatment of osteoporosis in Denmark. An economic evaluation based on the Fracture Intervention Trial]
Jönsson L, Borgström F, Zethraeus N
Ugeskrift for laeger 2003;165(43):4112-6

Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial
Cleland Jgf, Takala A, Apajasalo M, Zethraeus N, Kobelt G
EUROPEAN JOURNAL OF HEART FAILURE 2003;5(1):101-8

Modelling the cost-effectiveness of osteoporosis treatments the impact of patient compliance
Borgstrom F, Zethraeus N, Naujoks C
OSTEOPOROSIS INTERNATIONAL 2003;:S13-S13

Predicting survival in cost-effectiveness analyses based on clinical trials
Gerdtham Ug, Zethraeus N
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 2003;19(3):507-12

Femoral neck fractures in the elderly: Functional outcome and quality of life according to EuroQol
Tidermark J, Zethraeus N, Svensson O, Tornkvist H, Ponzer S
QUALITY OF LIFE RESEARCH 2002;11(5):473-81

Models for assessing the cost-effectiveness of the treatment and prevention of osteoporosis
Zethraeus N, Ben Sedrine W, Caulin F, Corcaud S, Gathon Hj, Haim M, et al
OSTEOPOROSIS INTERNATIONAL 2002;13(11):841-57

Sequential changes in quality of life after osteoporotic fractures
Johnell O, Kanis J, Delaet C, Jonsson B, Zethraeus N, Oden A
OSTEOPOROSIS INTERNATIONAL 2002;:S70-S70

Cost effectiveness of bisoprolol in the treatment of chronic congestive heart failure in Sweden - Analysis using data from the cardiac insufficiency bisoprolol study II trial
Ekman M, Zethraeus N, Jonsson B
PHARMACOECONOMICS 2001;19(9):901-16

Costs and benefits of laparoscopic surgery - a review of the literature
Jonsson B, Zethraeus N
EUROPEAN JOURNAL OF SURGERY 2000;:48-56

Costs and benefits of laparoscopic surgery--a review of the literature
Jönsson B, Zethraeus N
The European journal of surgery. Supplement. : = Acta chirurgica. Supplement 2000;(585):48-56

Definition, interpretation and calculation of cost-effectiveness acceptability curves
Lothgren M, Zethraeus N
HEALTH ECONOMICS 2000;9(7):623-30

A comparison of patient and social tariff values derived from the time trade-off method
Zethraeus N, Johannesson M
HEALTH ECONOMICS 1999;8(6):541-5

A computer model to analyze the cost-effectiveness of hormone replacement therapy
Zethraeus N, Johannesson M, Jonsson B
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 1999;15(2):352-65

Costs of coronary heart disease and stroke: the case of Sweden
Zethraeus N, Molin T, Henriksson P, Jonsson B
JOURNAL OF INTERNAL MEDICINE 1999;246(2):151-9

A note on confidence intervals in cost-effectiveness analysis
Tambour M, Zethraeus N, Johannesson M
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 1998;14(3):467-71

Bootstrap confidence intervals for cost-effectiveness ratios: Some simulation results
Tambour M, Zethraeus N
HEALTH ECONOMICS 1998;7(2):143-7

Estimating the costs of hip fracture and potential savings
Zethraeus N, Gerdtham Ug
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 1998;14(2):255-67

Nonparametric willingness-to-pay measures and confidence statements
Tambour M, Zethraeus N
MEDICAL DECISION MAKING 1998;18(3):330-6

Willingness to pay for hormone replacement therapy
Zethraeus N
HEALTH ECONOMICS 1998;7(1):31-8

The cost of a hip fracture - Estimates for 1,709 patients in Sweden
Zethraeus N, Stromberg L, Jonsson B, Svensson O, Ohlen G
ACTA ORTHOPAEDICA SCANDINAVICA 1997;68(1):13-7

The impact of hormone replacement therapy on quality of life and willingness to pay
Zethraeus N, Johannesson M, Henriksson P, Strand Rt
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY 1997;104(10):1191-5

A cost-minimization analysis of laparoscopic cholecystectomy versus open cholecystectomy
Berggren U, Zethraeus N, Arvidsson D, Haglund U, Jonsson B
AMERICAN JOURNAL OF SURGERY 1996;172(4):305-10

VALUE FOR MONEY - A CONTINGENT VALUATION STUDY OF THE OPTIMAL SIZE OF THE SWEDISH HEALTH-CARE BUDGET
Eckerlund I, Johannesson M, Johansson Po, Tambour M, Zethraeus N
HEALTH POLICY 1995;34(2):135-43

Visa alla publikationer

Karta